Tag: zynerba pharmaceuticals

August 13, 2019

Are US Marijuana Stocks a Good Buy?

The US has emerged as a cannabis powerhouse, but are US marijuana stocks a good buy for the average investor?
May 19, 2019

5 Top Weekly NASDAQ Biotech and Pharma Stocks: Index in Green

Last week's top NASDAQ biotech and pharma stocks were Harrow Health, Sesen Bio, Zynerba Pharmaceuticals, Athersys and Catalyst Pharmaceuticals.
May 6, 2019

Zynerba Jumps on Fast Track Designation Approval

The company has received fast track designation for its lead candidate, Zygel, which aims to treat patients with Fragile X...
May 6, 2019

Zynerba Pharmaceuticals Receives Fast Track Designation for Zygel™

Zynerba Pharmaceuticals (NASDAQ:ZYNE) has announced that the US Food and Drug Administration (FDA) has given fast track designation for the...
April 28, 2019

5 Top Weekly NASDAQ Biotech Stocks: Aratana Soars on Acquisition

Last week's other top NASDAQ biotech stocks were X4 Pharmaceuticals, Zynerba Pharmaceuticals, Vaccinex and Marinus Pharmaceuticals.
February 10, 2019

5 Top Weekly NASDAQ Biotech Stocks: Index Slips

Melinta Therapeutics, BioXcel Therapeutics, Eyenovia, Forward Pharma and Trevena were last week's top gainers.
December 13, 2018

Zynerba Pharmaceuticals Announces Sustained Improvements in Emotional and Behavioral Symptoms of Fragile X Syndrome

Zynerba Pharmaceuticals (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, is reporting new...